uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Analytical Chemistry.
Doping Control Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Department of Ecology, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Haematology.
2013 (English)In: Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, E-ISSN 1873-264X, Vol. 81-82, 187-192 p.Article in journal (Refereed) Published
Abstract [en]

The primary production site of erythropoietin (EPO) is shifted from the liver to the kidney shortly after birth. Under conditions of lost or reduced kidney production, it is valuable to measure the production capacity of the liver. However, there is a lack of urine or serum based methods that can distinguish endogenous EPO produced in different cell types. Here is presented a method based on chromatographic interaction with the lectin wheat germ agglutinin (WGA) that can distinguish presumably liver-produced EPO, found in anaemic patients receiving epoetin and darbepoetin, from kidney-produced EPO found in healthy individuals.

All the tested samples from haemodialysis patients with end-stage renal disease showed a presence of liver EPO. In some samples, the liver-produced EPO made up 90–100% of total EPO at a concentration of 8–10 ng/L in urine, which indicates that the liver has a quite high production capacity, although not adequate for the degree of anaemia.

This glycoform analysis has made it possible to affirm that some anaemic patients can increase their liver-production of EPO. The use of such a method can give better insight into the regulation of non-renal endogenous EPO production, a potential source of EPO intended to replace administration of exogenous EPO.

Place, publisher, year, edition, pages
2013. Vol. 81-82, 187-192 p.
Keyword [en]
EPO, Epoetin, Darbepoetin, Haemodialysis, Lectin chromatography, WGA
National Category
Chemical Sciences Medical and Health Sciences
URN: urn:nbn:se:uu:diva-202020DOI: 10.1016/j.jpba.2013.04.009ISI: 000319793500025OAI: oai:DiVA.org:uu-202020DiVA: diva2:630512
Available from: 2013-06-19 Created: 2013-06-19 Last updated: 2013-10-01Bibliographically approved

Open Access in DiVA

fulltext(665 kB)289 downloads
File information
File name FULLTEXT02.pdfFile size 665 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full texthttp://www.sciencedirect.com/science/article/pii/S0731708513001544

Search in DiVA

By author/editor
Lönnberg, MariaBirgegård, Gunnar
By organisation
Analytical ChemistryHaematology
In the same journal
Journal of Pharmaceutical and Biomedical Analysis
Chemical SciencesMedical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 290 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 448 hits
ReferencesLink to record
Permanent link

Direct link